Is this a side effect of comming past its sell-by date Paxil?
I have been on Paxil for the past 5 yrs. I started at 20 mg/day following a 16 mth long depression / anxiety. After 2 yrs I be brought down to 10mg and for the past 8 days, I am on 10mg every other day ( as prescribed by my doctor ) Everything is going well and emotionally I grain fine and am happy to be on my way of getting off of the medication after years of psychoanalysis and acceptance of my anxiety but this morning i woke up and i was extremely dizzy... i was wobbling when walking to the bathroom and have to hold my self with the wall.
I went to lay down and the room was spinning. It eventually passed after more or less 20 mins. Now again ( 4 hours later ) I have the same emotion and it has been approx 15 mins and it has passed.
Is this a side effect? I hold no other problems or feelings that are out of the ordinary but im wondering if I should just progress to 5mg / day instead of 10mg every other day?
any ideas or suggestions appreciated! gratitude:)
Answers:
Dizziness is a side affect of the drug and has been reported in just about 6-16% of the patients that have been prescribed the medication. here is the report:
Common adverse CNS effects due to paroxetine (incidence vs. placebo as listed) include anxiety or nervousness (5—9% vs 3—8%), dizziness (13—24% vs 6—16%), drowsiness (19—24% vs 5—11%), insomnia (13% vs 6%) and tremor (8—11% vs 1—2%). With continued treatment over 4—6 weeks, in attendance was evidence of adaptation to some adverse events with continued psychiatric therapy (e.g., dizziness). Approximately 2.3% of all patients require discontinuation due to somnolence; tremor leads to drug discontinuation in roughly 1% of patients. Other smaller amount common CNS effects of paroxetine (incidence vs. placebo as listed) may include abnormal dreams (4% vs. 1%), agitation (3—5% vs 1—4%), amnesia (2% vs 1%), confusion (1% vs 0%), depersonalization (3% vs 0%), impaired cognition or concentration (3—4% vs 0—2%), myoclonia (3% vs 1—2%), paresthesias (4% vs 2%), and a nonspecific drugged emotion (2% vs 1%). Yawning is a unique side effect and has been reported next to other SSRIs; increased yawning was reported in 4—5% of paroxetine-treated patients vs. 1% of those receiving placebo. In a pooled analysis, hallucination occurred in 0.2% of those receiving paroxetine versus 0.1% of those delivery placebo. Some CNS effects, including anorexia, dizziness, drowsiness, impaired cognition, tremor, xerostomia and yawning may respond to dosage reduction. Note that dependent on the disease state studied, some CNS events occurred surrounded by rates similar to placebo in controlled clinical trials. Source(s): MD Consult, Med school
Related Questions:
What is the instrument by which veinous blood returns to the heart from the foot?
Have sleeping tablets ever have an adverse effect on you?
Please... for a examination,I entail a nice and short explenation roughly speaking:?
I went to lay down and the room was spinning. It eventually passed after more or less 20 mins. Now again ( 4 hours later ) I have the same emotion and it has been approx 15 mins and it has passed.
Is this a side effect? I hold no other problems or feelings that are out of the ordinary but im wondering if I should just progress to 5mg / day instead of 10mg every other day?
any ideas or suggestions appreciated! gratitude:)
Answers:
Dizziness is a side affect of the drug and has been reported in just about 6-16% of the patients that have been prescribed the medication. here is the report:
Common adverse CNS effects due to paroxetine (incidence vs. placebo as listed) include anxiety or nervousness (5—9% vs 3—8%), dizziness (13—24% vs 6—16%), drowsiness (19—24% vs 5—11%), insomnia (13% vs 6%) and tremor (8—11% vs 1—2%). With continued treatment over 4—6 weeks, in attendance was evidence of adaptation to some adverse events with continued psychiatric therapy (e.g., dizziness). Approximately 2.3% of all patients require discontinuation due to somnolence; tremor leads to drug discontinuation in roughly 1% of patients. Other smaller amount common CNS effects of paroxetine (incidence vs. placebo as listed) may include abnormal dreams (4% vs. 1%), agitation (3—5% vs 1—4%), amnesia (2% vs 1%), confusion (1% vs 0%), depersonalization (3% vs 0%), impaired cognition or concentration (3—4% vs 0—2%), myoclonia (3% vs 1—2%), paresthesias (4% vs 2%), and a nonspecific drugged emotion (2% vs 1%). Yawning is a unique side effect and has been reported next to other SSRIs; increased yawning was reported in 4—5% of paroxetine-treated patients vs. 1% of those receiving placebo. In a pooled analysis, hallucination occurred in 0.2% of those receiving paroxetine versus 0.1% of those delivery placebo. Some CNS effects, including anorexia, dizziness, drowsiness, impaired cognition, tremor, xerostomia and yawning may respond to dosage reduction. Note that dependent on the disease state studied, some CNS events occurred surrounded by rates similar to placebo in controlled clinical trials. Source(s): MD Consult, Med school
Related Questions: